Sivan et al. [47] originally showed in animal studies that the gut microbiota might influence the tumor immune microenvironment because Bifidobacterium bifidum improved DC activity, which improved CD8+ T cell initiation and anti-PD-L1 efficacy. Here, CD274 is linked to neoplasm.